Virtual Medicinal Product (VMP) - Cefpodoxime 40mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Cefpodoxime 40mg/5ml oral suspension | Start Date 24-02-2003 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5.0
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- J01DD13
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 05010201 | Start Date 04-04-2022 | End Date |
| Previous BNF 05010201 | Start Date 06-03-2009 | End Date 12-06-2014 |
| Previous BNF 05010200 | Start Date 01-02-2005 | End Date 05-03-2009 |
| Code | Start Date | End Date |
|---|---|---|
| 35369711000001108 | 18-04-2018 | |
| 323984000 | 24-02-2003 | 17-04-2018 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Cefpodoxime proxetil | Based on Base Substance | Cefpodoxime | 8 mg | 1 ml |
Name
Cefpodoxime proxetil
Basis of strength description
Based on Base Substance
BOSS
Cefpodoxime
Strength and UOM (Nmr)
8.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMCefpodoxime
-
VMP(Current) Cefpodoxime 40mg/5ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 50 ml | ||
| 100 ml |